Carboplatin/Cisplatin + Pemetrexed (Cohort B2 Only)

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid TumorsNCT07397338RVMDPhase 1, Phase 2Recruiting2029-05Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.